Save the Date: The 16th Zhejiang University Colorectal Cancer Symposium
May 15–17 | Join the Live Online Broadcast
Globally, colorectal cancer is the third most commonly diagnosed malignancy and the second leading cause of cancer-related death, placing a substantial burden on public health worldwide. Owing to its large population base, China accounts for 28.76% of global colorectal cancer incidence and 30.60% of related deaths, making it a major driving force in advancing colorectal cancer prevention and treatment worldwide. In recent years, breakthroughs in innovative drug development, novel surgical techniques, and robotic-assisted surgery in China have significantly advanced the global standard of colorectal cancer care.
As a Vice Chair institution of the China “Belt and Road” Health Professionals Development Alliance, the Second Affiliated Hospital, Zhejiang University School of Medicine, is committed to sharing China’s advanced clinical expertise with the international medical community. In the field of colorectal cancer, the hospital established the International College of Surgery Training Academy of China (ICSTAC), which provides comprehensive theoretical education and hands-on surgical training for physicians from countries including Italy, Mexico, and India. To date, numerous international trainees have successfully completed the program and are now actively engaged in colorectal cancer prevention and treatment efforts in their respective countries.
From May 15 to 17, 2026 (Beijing Time), the 16th Zhejiang University Colorectal Cancer Symposium will officially take place. The meeting is hosted by the Zhejiang Anti-Cancer Association, co-organized by the Journal of Practical Oncology, and organized by the Second Affiliated Hospital, Zhejiang University School of Medicine. Centered on the theme of “Standardized Multidisciplinary and Precision Management of Colorectal Cancer,” the symposium will highlight the latest advances in global clinical research and explore major academic controversies in the field.
Over the course of the three-day conference, participants will gain insights into China’s leading achievements in colorectal cancer surgery, cutting-edge applications of artificial intelligence and robotics, emerging targets for precision therapy, innovative drug development, multidisciplinary management, patient care, nutritional support, and many other important topics. An outstanding academic program awaits.
Live Streaming Information
Date: May 15–17, 2026 (Beijing Time)
To watch the livestream, please visit the official conference website below:
https://mm.sciconf.cn/cn/minisite/index/35357?sessionid=
